Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
May 27, 2025
Join us in San Francisco, CA, USA, July 12-15, 2025, for ENDO 2025. With over 7,000 attendees, nearly 2,500 abstracts and over 200 other sessions, ENDO is the leading global meeting on endocrinology research and clinical care. ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world.
June 13, 2025
Registration is open for our leading online training program for fellows, residents, and physicians preparing for the board certification exam. Maximize your score in Endocrinology, Diabetes, & Metabolism with a study guide and expert insights. Registration includes a printed book, interactive practice exams, and topical Q&A sessions. Register now
June 13, 2025
Discover the latest advances in hormone health treatments at CEU 2025 on October 23- 25. Our comprehensive, case-based agenda will help you gain new skills that you can immediately apply in your practice. Join the best in clinical sessions covering nine topical categories and earn up to 27 AMA PRA Category 1 Credits™. Eligible physicians may also claim up to 9 ABIM MOC Points. Register today
June 04, 2025
Navigate the complexities of endocrine care for children and adolescents with the Pediatric Endocrine Self-Assessment Program (ESAP)™ 2025–2026. Enhance patient care with 100 new case-based questions covering growth, diabetes, reproduction, and more. Available in print, eBook, and online, with interactive modes to build knowledge and confidence. Order now.
June 27, 2025
Learn about the latest in our advocacy efforts, including updates on NIH funding, the Diabetes Prevention Program Outcomes Study, regulation of EDCs in the EU, and protection of access to vaccines.
Need more info?
Learn more about the advantages of membership
June 18, 2025
As experts dedicated to providing patients with compassionate, evidence-based care every day, we are disappointed in the United States vs. Skrmetti decision, which increases the likelihood that other states will limit or eliminate families’ and patients’ ability to access medical care.
June 10, 2025
The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications.
June 05, 2025
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate.
June 24, 2025
The authors present a 64-year-old woman who developed fatal, fulminant, necrotizing pancreatitis after recently initiated tirzepatide 2.5 mg weekly for weight loss and no history of type 2 diabetes mellitus.
June 24, 2025
This review synthesizes current knowledge on the neurotoxic mechanisms of flame retardants, highlighting their impact on anxiety and cognition across developmental stages.
June 24, 2025
We identify fracture predictors in persons with type 2 diabetes and overweight or obesity, considering traditional and diabetes-related risk factors.
